Fady Ibraham Malik, EVP Research & Development at Cytokinetics, holds 114.92K shares in Cytokinetics (Ticker: CYTK), holds ― shares in Rocket Pharmaceuticals (Ticker: RCKT).
What is the percentage of profitable transactions made by Fady Ibraham Malik?
The percentage of profitable transactions made by Fady Ibraham Malik is 55%.
What is the average return per transaction made by Fady Ibraham Malik?
The average return per transaction made by Fady Ibraham Malik is -18.30%.
What stocks does Fady Ibraham Malik hold?
Fady Ibraham Malik holds: CYTK, RCKT stocks.
What was Fady Ibraham Malik’s latest transaction?
Fady Ibraham Malik latest transaction was an Uninformative Buy of $42.19K.
What was Fady Ibraham Malik's most profitable transaction?
Fady Ibraham Malik’s most profitable transaction was an Informative Sell of CYTK stock on December 30, 2016. The return on the trade was 32.90%.
What is Fady Ibraham Malik's role in Cytokinetics?
Fady Ibraham Malik's role in Cytokinetics is EVP Research & Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.